COMP <GO>
CAH vs HLF // GROSS PROFIT MARGIN
Cardinal Health Inc. (NYSE) VS. Herbalife Ltd. (NYSE) • 15-METRIC TALLY: CAH 4
— HLF 8
▲ GROSS PROFIT MARGIN LEADER: HLF
LAST: $251.09 (+2.59%) • MKT CAP: $58.14B
gross-margins
3.70%
LAST: $12.93 (-3.36%) • MKT CAP: $1.36B
gross-margins
77.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CAH VS. HLF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CAH | HLF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 3.70% | 77.90% | -74.20 | HLF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 29.70% | 34.40% | -4.70 | HLF | /roic <GO> |
| EV/EBITDA & P/E Valuation | 24.5x | 5.4x | +19.10 | HLF | /valuation <GO> |
| Free Cash Flow Yield | 3.18% | 18.66% | -15.48 | HLF | /fcf-yield <GO> |
| Operating Margin | 1.00% | 9.50% | -8.50 | HLF | /operating-margins <GO> |
| Net Profit Margin | 0.70% | 4.50% | -3.80 | HLF | /net-margins <GO> |
| Revenue Growth (YoY) | -1.90% | 0.90% | -2.80 | HLF | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.85% | 0.00% | +0.85 | CAH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.16 | 2.39 | +2.77 | CAH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.1 | 47.5 | +11.58 | CAH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.6x | 5.5x | +29.10 | HLF | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $58.14B | $1.36B | $56.79B | CAH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CAH REV | HLF REV | CAH GROSS % | HLF GROSS % | CAH FCF | HLF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $222.58B | $5.04B | 3.7% | 77.9% | $1.85B | $252.9M |
| FY 2024 | $226.83B | $4.99B | 3.3% | 77.9% | $3.25B | $163.4M |
| FY 2023 | $204.98B | $5.06B | — | — | -$6.38B | $357.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CAH // BETA 0.90
HLF // BETA —